These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16325941)

  • 1. An intriguing case of primary amyloidosis with cardiac involvement: symptomatic and echocardiographic improvement with thalidomide treatment.
    Oh IY; Kim HK; Kim YJ; Sohn DW; Park YB
    Int J Cardiol; 2006 Oct; 113(1):141-3. PubMed ID: 16325941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement after thalidomide and dexamethasone treatment for advanced cardiac amyloidosis: a case report.
    Choi JS; Hwang EN; Kim YH; Jung Y; Kim HJ; Nam SH; Park JI
    Circ J; 2007 Nov; 71(11):1823-5. PubMed ID: 17965510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide.
    Palladini G; Russo P; Lavatelli F; Nuvolone M; Albertini R; Bosoni T; Perfetti V; Obici L; Perlini S; Moratti R; Merlini G
    Ann Hematol; 2009 Apr; 88(4):347-50. PubMed ID: 18779964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The return of the normal heart: resolution of cardiac amyloidosis after chemotherapy and bone marrow transplantation.
    Fitzgerald BT; Bashford J; Scalia GM
    Heart Lung Circ; 2013 Aug; 22(8):655-60. PubMed ID: 23474152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early improvement in cardiac function detected by tissue Doppler and strain imaging after melphalan-dexamethasone therapy in a 51-year old subject with severe cardiac amyloidosis.
    Ballo P; Motto A; Corsini F; Orlandini F; Mondillo S
    Int J Cardiol; 2008 Nov; 130(2):278-82. PubMed ID: 17719107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac amyloidosis cases with relative apical sparing of longitudinal strain.
    Bostan C; Sinan UY; Canbolat P; Kucukoglu S
    Echocardiography; 2014 Feb; 31(2):241-4. PubMed ID: 24304289
    [No Abstract]   [Full Text] [Related]  

  • 7. Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis.
    Liu D; Niemann M; Hu K; Herrmann S; Störk S; Knop S; Ertl G; Weidemann F
    Am J Cardiol; 2011 Aug; 108(4):591-8. PubMed ID: 21807135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Augmentation of left ventricular outflow tract gradient by digitalis glycosides in a case of cardiac (AL-) amyloidosis].
    Petzsch M; Pulya K; Anders O
    Dtsch Med Wochenschr; 2001 Aug; 126(33):909-12. PubMed ID: 11514926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide.
    Palladini G; Russo P; Foli A; Milani P; Lavatelli F; Obici L; Nuvolone M; Brugnatelli S; Invernizzi R; Merlini G
    Ann Hematol; 2012 Jan; 91(1):89-92. PubMed ID: 21533608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review.
    Freeman B; Sloan JM; Seldin DC; Cowan AJ; Ruberg FL; Sanchorawala V
    Amyloid; 2012 Sep; 19(3):156-60. PubMed ID: 22680044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac amyloidosis--sustained clinical and free light chain response to low dose thalidomide and corticosteroids.
    Campbell P; Murdock C
    Intern Med J; 2006 Feb; 36(2):137-9. PubMed ID: 16472271
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of cardiac AA amyloidosis].
    Biesenbach E; Nia A; Caglayan E; Er F; Gassanov N
    Dtsch Med Wochenschr; 2012 Jun; 137(25-26):1356-9. PubMed ID: 22692837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.
    Mahmood S; Venner CP; Sachchithanantham S; Lane T; Rannigan L; Foard D; Pinney JH; Gibbs SD; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Br J Haematol; 2014 Sep; 166(6):842-8. PubMed ID: 24930361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac amyloidosis revealing multiple myeloma].
    Denguir H; Ben-Hamda K; Gharbi M; Addad F; Hammami S; Mlika A; Abbes F; Moussa A; Betbout F; Gamra H; Maatouk F; Dridi Z; Zakhama A; Mahjoub S; Ben-Farhat M
    Tunis Med; 2005 May; 83(5):300-4. PubMed ID: 16044906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Original case report of amyloidosis with pleural involvement: the role of echocardiography in the diagnosis].
    Roubille F; Billotet C; Roubille C
    Rev Med Interne; 2006 Oct; 27(10):794-6. PubMed ID: 16797793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of triplet regimens in newly diagnosed light chain amyloidosis.
    Chari A; Barley K; Jagannath S; Osman K
    Clin Lymphoma Myeloma Leuk; 2013 Feb; 13(1):55-61. PubMed ID: 23098888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical benefits of bortezomib-containing regimens for newly diagnosed AL amyloidosis with severe cardiac impairment].
    Tsukune Y; Yahata Y; Sasaki M; Hiki M; Tsutsui M; Hamano Y; Itoh S; Miyazaki T; Dohi T; Maruyama M; Gotoh A; Komatsu N
    Rinsho Ketsueki; 2016 Aug; 57(8):987-93. PubMed ID: 27599413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of fragmented QRS in cardiac AL amyloidosis.
    Perlini S; Salinaro F; Cappelli F; Perfetto F; Bergesio F; Alogna A; Mussinelli R; Boldrini M; Raimondi A; Musca F; Palladini G; Merlini G
    Int J Cardiol; 2013 Sep; 167(5):2156-61. PubMed ID: 22748496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall.
    Oki T; Tanaka H; Yamada H; Tabata T; Oishi Y; Ishimoto T; Nagase N; Shinohara H; Sakabe K; Fukuda N
    Am J Cardiol; 2004 Apr; 93(7):864-9. PubMed ID: 15050490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel drug therapies for cardiac amyloidosis.
    Harikrishnan P; Yandrapalli S; Aronow WS; Lanier GM; Jain D
    Expert Opin Investig Drugs; 2019 Jun; 28(6):497-499. PubMed ID: 31084448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.